ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Leiden University Medical Center at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Leiden University Medical Center takes part in 9 sessions at ESMO 2026 in Madrid. Its work spans lung, breast, pancreatic and other cancers, alongside precision medicine and treatment policy. It examines whether older patients with early breast cancer can avoid radiotherapy after breast-conserving surgery.
| Organization | ESMO 2026 Attendance |
|---|---|
Leiden University Medical Center Leiden, Netherlands | |
Academic hospital and medical faculty of Leiden University in Leiden, Netherlands. | Poster Fri Oct 23 13:00–15:00 Genomic characterization of pancreatic ductal adenocarcinomas in individuals with a germline CDKN2A/p16 pathogenic variant Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 Efficacy of panitumumab monotherapy in patients with advanced or metastatic RAS/RAF wild-type (wt) tumors: Results from the Drug Rediscovery Protocol (DRUP) Sarcoma, CNS, head & neck and rare cancersMelanoma & skin cancersGenitourinary cancersGastrointestinal cancersGynaecological cancers Abstract Fri Oct 23 17:19–17:24 Chair Sat Oct 24 08:30–10:00 Rapid oral 1: NSCLC, metastatic Lung & thoracic cancers Abstract Sat Oct 24 09:32–09:44 Invited Discussant 2631RO and 2658RO Lung & thoracic cancers Abstract Sun Oct 25 08:57–09:02 Abstract Sun Oct 25 10:15–10:25 Poster Sun Oct 25 12:00–12:45 Poster Sun Oct 25 12:00–12:45 Poster Mon Oct 26 12:00–12:45 Pimicotinib in patients with tenosynovial giant cell tumour (TGCT): 2-year analysis of the phase 3 MANEUVER trial Sarcoma, CNS, head & neck and rare cancers Poster Mon Oct 26 12:00–12:45 |
Find decision makers at Leiden University Medical Center
Tell us what you sell and we’ll find the people at Leiden University Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction